Hepatocellular Carcinoma and Transarterial Chemo-Embolization

The most well-known kind of adult essential liver growth and the most common cause of death in cirrhotic people is hepatocellular carcinoma (HCC). It occurs when the liver is constantly becoming worse and is most strongly linked to chronic viral hepatitis infection (hepatitis B or C) or exposure to toxins like alcohol or aflatoxin. Alpha 1-antitrypsin deficiency and hemochromatosis are two conditions that increase the risk of treating HCC. Similar to other malignancies, HCC therapy and prognosis depend on the characteristics of the, tumor's histology measurement, extent of growth, and overall health.

 

    Related Conference of Hepatocellular Carcinoma and Transarterial Chemo-Embolization

    December 07-08, 2022

    45th World Strock Summit

    Prague, Czech Republic
    December 19-20, 2022

    2nd World Conference on Gastroenterology and Digestive Diseases

    Amsterdam, Netherlands
    April 17-18, 2023

    18th Euro-Global Gastroenterology Conference

    Barcelona, Spain
    May 22-23, 2023

    14th International Conference on Liver Diseases & Hepatology

    Amsterdam, Netherlands
    July 18-19, 2023

    2nd International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    July 26-27, 2023

    12th International Conference on Hepatitis & Liver Diseases

    Singapore City, Singapore
    August 23-24, 2023

    29th World Conference on Gastroenterology & Hepatology

    Toronto, Canada
    August 30-31, 2023

    22st World Congress on Gastrointestinal Cancer

    Dublin, Ireland
    November 29-30, 2023

    12th World Gastro Summit

    Amsterdam, Netherlands

    Hepatocellular Carcinoma and Transarterial Chemo-Embolization Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in